ProQR Therapeutics N.V. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2025: USD 11.53 K

ProQR Therapeutics N.V. Common Stock Issued is USD 11.53 K for the Trailing 12 Months (TTM) ending March 31, 2025, a -97.93% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.
  • ProQR Therapeutics N.V. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 556.56 K, a -96.32% change year over year.
  • ProQR Therapeutics N.V. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 15.11 M, a 1,004.46% change year over year.
  • ProQR Therapeutics N.V. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.37 M, a -56.03% change year over year.
  • ProQR Therapeutics N.V. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 3.11 M, a -94.29% change year over year.
Key Data
Date Common Stock Issued Common Stock Repurchased Free Cash Flow Operating Cash Flow